Abstract
Antimicrobial resistance is a serious public health threat worldwide today. Escherichia coli is known to resist low doses of antibiotics in the presence of sodium salicylate and related compounds by mounting non-heritable transient phenotypic antibiotic resistance (PAR). In the present study, we demonstrate that Bgl+ bacterial strains harboring a functional copy of the β-glucoside (bgl) operon and are actively hydrolyzing plant-derived aromatic β-glucosides such as salicin show PAR to low doses of antibiotics. The aglycone released during metabolism of aromatic β-glucosides is responsible for conferring this phenotype by de-repressing the multiple antibiotics resistance (mar) operon. We also show that prolonged exposure of Bgl+ bacteria to aromatic β-glucosides in the presence of sub-lethal doses of antibiotics can lead to a significant increase in the frequency of mutants that show heritable resistance to higher doses of antibiotics. Although heritable drug resistance in many cases is known to reduce the fitness of the carrier strain, we did not see a cost associated with resistance in the mutants, most of which carry clinically relevant mutations. These findings indicate that the presence of the activated form of the bgl operon in the genome facilitates the survival of bacteria in environments in which both aromatic β-glucosides and antibiotics are present.
Similar content being viewed by others
Abbreviations
- PAR:
-
Phenotypic antibiotic resistance
- NaSal:
-
Sodium salicylate
- SG:
-
Saligenin
- MIC:
-
Minimal inhibitory concentration
References
Andersson DI, Hughes D (2012) Evolution of antibiotic resistance at non-lethal drug concentrations. Drug Resist Updat 15:162–172
Andersson DI, Hughes D (2014) Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol 12:465
Baquero F, Martínez J-L, Cantón R (2008) Antibiotics and antibiotic resistance in water environments. Curr Opin Biotechnol 19:260–265
Bhaskarla C, Das M, Verma T, Kumar A, Mahadevan S, Nandi D (2016) Roles of Lon protease and its substrate MarA during sodium salicylate-mediated growth reduction and antibiotic resistance in Escherichia coli. Microbiology 162:764–776
Björkman J, Andersson DI (2000) The cost of antibiotic resistance from a bacterial perspective. Drug Resist Updat 3:237–245
Cohen SP, Levy SB, Foulds J, Rosner JL (1993) Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway. J Bacteriol 175:7856–7862
Corona F, Martinez J (2013) Phenotypic resistance to antibiotics. Antibiotics 2:237–255
Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97:6640–6645
Fram MS, Belitz K (2011) Occurrence and concentrations of pharmaceutical compounds in groundwater used for public drinking-water supply in California. Sci Total Environ 409:3409–3417
Gillespie SH, Voelker LL, Dickens A (2002) Evolutionary barriers to quinolone resistance in Streptococcus pneumoniae. MDR 8:79–84
Gullberg E, Cao S, Berg OG, Ilbäck C, Sandegren L, Hughes D, Andersson DI (2011) Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog 7:e1002158
Harwani D, Zangoui P, Mahadevan S (2012) The β-glucoside (bgl) operon of Escherichia coli is involved in the regulation of oppA encoding an oligo-peptide transporter. J Bacteriol 194:90–99
Hughes D, Andersson DI (2015) Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms. Nat Rev Genet 16:459
Jiang L, Hu X, Xu T, Zhang H, Sheng D, Yin D (2013) Prevalence of antibiotic resistance genes and their relationship with antibiotics in the Huangpu River and the drinking water sources, Shanghai, China. Sci Total Environ 458:267–272
Khan GA, Berglund B, Khan KM, Lindgren P-E, Fick J (2013) Occurrence and abundance of antibiotics and resistance genes in rivers, canal and near drug formulation facilities—a study in Pakistan. PLoS One 8:e62712
Lai X, Davis F, Hespell R, Ingram L (1997) Cloning of cellobiose phosphoenolpyruvate-dependent phosphotransferase genes: functional expression in recombinant Escherichia coli and identification of a putative binding region for disaccharides. Appl Environ Microbiol 63:355–363
Levy SB (1992) The antibiotic paradox: from tragedy the antibiotic age is born. Springer, Berlin.
Lindgren PK, Karlsson Å, Hughes D (2003) Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother 47:3222–3232
Liu A, Fong A, Becket E, Yuan J, Tamae C, Medrano L, Maiz M, Wahba C, Lee C, Lee K (2011) Selective advantage of resistant strains at trace levels of antibiotics: a simple and ultrasensitive color test for detection of antibiotics and genotoxic agents. Antimicrob Agents Chemother 55:1204–1210
Lopilato J, and Wright A (1990) Mechanisms of activation of the cryptic bgl operon of Escherichia coli K-12. In: Drlica K, Riley M (eds) The bacterial chromosome. American society for microbiology, Washington, DC, pp 435–444
Ma D, Cook DN, Hearst JE, Nikaido H (1994) Efflux pumps and drug resistance in gram-negative bacteria. Trends Microbiol 2:489–493
Madan R, Kolter R, Mahadevan S (2005) Mutations that activate the silent bgl operon of Escherichia coli confer a growth advantage in stationary phase. J Bacteriol 187:7912–7917
Mahadevan S, Reynolds A, Wright A (1987) Positive and negative regulation of the bgl operon in Escherichia coli. J Bacteriol 169:2570–2578
Mazzariol A, Tokue Y, Kanegawa TM, Cornaglia G, Nikaido H (2000) High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob Agents Chemother 44:3441–3443
Melnyk AH, Wong A, Kassen R (2015) The fitness costs of antibiotic resistance mutations. Evol Appl 8:273–283
Mukerji M, Mahadevan S (1997a) Characterization of the negative elements involved in silencing the bgl operon of Escherichia coli : possible roles for DNA gyrase, H-NS, and CRP–cAMP in regulation. Mol Microbiol 24:617–627
Mukerji M, Mahadevan S (1997b) Cryptic genes: evolutionary puzzles. J Genet 76:147–159
Nakamura S, Nakamura M, Kojima T, Yoshida H (1989) gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob Agents Chemother 33:254–255
Oethinger M, Kern WV, Jellen-Ritter AS, McMurry LM, Levy SB (2000) Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 44:10–13
Piddock LJ (2006) Multidrug-resistance efflux pumps? Not just for resistance. Nat Rev Microbiol 4:629
Poole K (2004) Efflux-mediated multiresistance in Gram-negative bacteria. Clin Microbiol Infect 10:12–26
Price CT, Lee IR, Gustafson JE (2000) The effects of salicylate on bacteria. Int J Biochem Cell Biol 32:1029–1043
Raghunand TR, Mahadevan S (2003) The β-glucoside genes of Klebsiella aerogenes: conservation and divergence in relation to the cryptic bgl genes of Escherichia coli. FEMS Microbiol Lett 223:267–274
Redgrave LS, Sutton SB, Webber MA, Piddock LJ (2014) Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol 22:438–445
Reynolds AE, Felton J, Wright A (1981) Insertion of DNA activates the cryptic bgl operon in E. coli K12. Nature 293:625–629
Reynolds AE, Mahadevan S, LeGrice SF, Wright A (1986) Enhancement of bacterial gene expression by insertion elements or by mutation in a CAP-cAMP binding site. J Mol Biol 191:85–95
Rosner JL (1985) Nonheritable resistance to chloramphenicol and other antibiotics induced by salicylates and other chemotactic repellents in Escherichia coli K-12. Proc Natl Acad Sci USA 82:8771–8774
Saier M Jr, Tam R, Reizer A, Reizer J (1994) Two novel families of bacterial membrane proteins concerned with nodulation, cell division and transport. Mol Microbiol 11:841–847
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd ed. Cold spring harbor press, Cold spring harbor, New york
Sambrook J, Russell DW, and Maniatis T (2001). Molecular cloning, vol 1–3. Cold Spring habour laboratory press, New York.
Sandegren L (2014) Selection of antibiotic resistance at very low antibiotic concentrations. Ups J Med Sci 119:103–107
Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3:1101
Schnetz K (1995) Silencing of Escherichia coli bgl promoter by flanking sequence elements. EMBO J 14:2545–2550
Schnetz K, Rak B (1992) IS5: a mobile enhancer of transcription in Escherichia coli. Proc Natl Acad Sci USA 89:1244–1248
Shuster Y, Steiner-Mordoch S, Cudkowicz NA, Schuldiner S (2016) A transporter interactome is essential for the acquisition of antimicrobial resistance to antibiotics. PLoS One 11:e0152917
Singh J, Mukerji M, Mahadevan S (1995) Transcriptional activation of the Escherichia coli bgl operon: negative regulation by DNA structural elements near the promoter. Mol Microbiol 17:1085–1092
Sonowal R, Nandimath K, Kulkarni SS, Koushika SP, Nanjundiah V, Mahadevan S (2013) Hydrolysis of aromatic β-glucosides by non-pathogenic bacteria confers a chemical weapon against predators. Proc R Soc B 280:20130721
Tseng T-T, Gratwick KS, Kollman J, Park D, Nies DH, Goffeau A, Saier MH Jr (1999) The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins. J Mol Microbiol Biotechnol 1:107–125
Webber MA, Piddock LJ (2001) Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli. Antimicrob Agents Chemother 45:1550–1552
Yoshida H, Bogaki M, Nakamura M, Nakamura S (1990) Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 34:1271–1272
Acknowledgements
This study was funded by the Department of Biotechnology (DBT) through a partnership programme with the Indian Institute of Science. The authors are also grateful to the Department of Science and Technology (DST-FIST) and the Universities Grants Commission (UGC) for infrastructural support. KV is a recipient of a research fellowship from the Indian Institute of Science. SM acknowledges additional financial support from the Indian Institute of Science.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Erko Stackebrandt.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Vashishtha, K., Mahadevan, S. Catabolism of aromatic β-glucosides by bacteria can lead to antibiotics resistance. Arch Microbiol 202, 1301–1315 (2020). https://doi.org/10.1007/s00203-020-01836-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00203-020-01836-9